Aurinia Pharmaceuticals Inc - stock earnings
AUPH Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| May 2, 2024 BeforeMarket | -0.03 / -0.14 | - | 50.3 million / 48.4 million | - |
| Aug. 1, 2024 BeforeMarket | - / - | 49.0 million | - / 53.6 million | 57.1 million |
AUPH Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2024Q1 | -10.7 million USD | 50.3 million USD |
| 2023Q4 | -26.9 million USD | 45.1 million USD |
| 2023Q3 | -13.4 million USD | 54.5 million USD |
| 2023Q2 | -11.5 million USD | 41.5 million USD |
| 2023Q1 | -26.2 million USD | 34.4 million USD |
| 2022Q4 | -26.0 million USD | 28.4 million USD |
| 2022Q3 | -9.0 million USD | 55.8 million USD |
| 2022Q2 | -35.5 million USD | 28.2 million USD |
| 2022Q1 | -37.6 million USD | 21.6 million USD |
| 2021Q4 | -33.3 million USD | 23.4 million USD |
| 2021Q3 | -50.3 million USD | 14.7 million USD |
| 2021Q2 | -47.0 million USD | 6.6 million USD |
| 2021Q1 | -50.4 million USD | 914000 USD |
| 2020Q4 | -8.1 million USD | 50.0 million USD |
| 2020Q3 | -34.1 million USD | 29000 USD |
| 2020Q2 | -29.5 million USD | 29000 USD |
| 2020Q1 | -16.5 million USD | 30000 USD |
| 2019Q4 | -76.5 million USD | 29000 USD |
| 2019Q3 | -19.0 million USD | 230000 USD |
| 2019Q2 | -15.9 million USD | 29000 USD |
| 2019Q1 | -12.4 million USD | 30000 USD |
| 2018Q4 | -14.6 million USD | 29000 USD |
| 2018Q3 | -18.3 million USD | 375000 USD |
| 2018Q2 | -15.7 million USD | 29000 USD |
| 2018Q1 | -15.5 million USD | 30000 USD |
| 2017Q4 | -3.3 million USD | 31000 USD |
| 2017Q3 | -13.1 million USD | 29000 USD |
| 2017Q2 | -2.4 million USD | 329000 USD |
| 2017Q1 | -51.9 million USD | 31000 USD |
| 2016Q4 | -8.3 million USD | 30000 USD |
| 2016Q3 | -7.4 million USD | 31000 USD |
| 2016Q2 | -3.3 million USD | 55000 USD |
| 2016Q1 | -4.3 million USD | 57000 USD |
| 2015Q4 | -3.9 million USD | 57000 USD |
| 2015Q3 | -5.2 million USD | 57000 USD |
| 2015Q2 | -733000 USD | 59000 USD |
| 2015Q1 | -8.6 million USD | 62000 USD |
| 2014Q4 | -4.9 million USD | 68000 USD |
| 2014Q3 | -2.5 million USD | 72000 USD |
| 2014Q2 | -4.0 million USD | 71000 USD |
| 2014Q1 | -5.2 million USD | 67000 USD |
| 2013Q4 | 1.6 million USD | 692643 USD |
| 2013Q3 | -2.2 million USD | 84336 USD |
| 2013Q2 | -988442 USD | 82687 USD |
| 2013Q1 | -779399 USD | 87473 USD |
| 2012Q4 | -5.2 million USD | 86207 USD |
| 2012Q3 | -1.7 million USD | 87376 USD |
| 2012Q2 | -2.3 million USD | 88486 USD |
| 2012Q1 | -455042 USD | 5.8 million USD |
| 2011Q4 | -6.3 million USD | 119966 USD |
| 2011Q3 | 2.2 million USD | 534836 USD |
| 2011Q2 | 4.9 million USD | 152810 USD |
| 2011Q1 | -3.0 million USD | 137872 USD |
| 2010Q4 | -2.5 million USD | 297754 USD |
| 2010Q3 | -1.5 million USD | 263616 USD |
| 2010Q2 | -461056 USD | 1.4 million USD |
| 2010Q1 | 780851 USD | 1.4 million USD |
| 2009Q4 | -1.6 million USD | 1.7 million USD |
| 2009Q3 | -1.7 million USD | 959865 USD |
| 2009Q2 | -406563 USD | 618459 USD |
| 2009Q1 | -3.3 million USD | 647026 USD |
| 2008Q4 | -2.2 million USD | 93447 USD |
| 2008Q3 | -3.5 million USD | 2.7 million USD |
| 2008Q2 | -5.3 million USD | 555118 USD |
| 2008Q1 | -5.2 million USD | 562518 USD |
| 2007Q4 | -8.6 million USD | 616273 USD |
| 2007Q3 | -7.4 million USD | 553988 USD |
| 2007Q2 | -9.3 million USD | 429309 USD |
| 2007Q1 | -6.7 million USD | 605929 USD |
| 2006Q4 | -5.8 million USD | 637999 USD |
| 2006Q3 | -6.3 million USD | 519434 USD |
| 2006Q2 | -6.0 million USD | 936995 USD |
| 2006Q1 | -4.6 million USD | 1.4 million USD |
| 2005Q4 | -9.4 million USD | -1.1 million USD |
| 2005Q3 | -5.5 million USD | 1.8 million USD |
| 2005Q2 | -6.5 million USD | 204074 USD |
| 2005Q1 | -7.0 million USD | 317434 USD |
| 2004Q4 | -8.7 million USD | 255476 USD |
| 2004Q3 | -7.2 million USD | 262450 USD |
| 2004Q2 | -3.4 million USD | 255033 USD |
| 2004Q1 | -2.9 million USD | 467503 USD |
| 2003Q4 | -6.8 million USD | 615631 USD |
| 2003Q3 | -4.6 million USD | 306914 USD |
| 2003Q2 | 1.1 million USD | 6.5 million USD |
| 2003Q1 | -4.0 million USD | 215972 USD |
| 2002Q4 | -2.8 million USD | 300445 USD |
| 2002Q3 | 2.5 million USD | 4.2 million USD |
| 2002Q2 | 2.1 million USD | 5.5 million USD |
| 2002Q1 | -2.1 million USD | 2.2 million USD |
| 2001Q4 | ? USD | 3.2 million USD |
| 2001Q3 | ? USD | 255676 USD |
| 2001Q2 | -2.1 million USD | 522691 USD |
| 2001Q1 | -3.1 million USD | 522269 USD |
| 2000Q4 | -2.1 million USD | 447750 USD |
| 2000Q3 | -2.4 million USD | 299185 USD |
| 2000Q2 | -1.4 million USD | 249175 USD |
| 2000Q1 | -1.7 million USD | 66740 USD |
| 1999Q4 | -758066 USD | 275660 USD |
| 1999Q3 | -887828 USD | 488370 USD |
| 1999Q2 | 66909 USD | 200729 USD |
| 1999Q1 | -474740 USD | 271280 USD |
| 1998Q4 | 66291 USD | 397746 USD |
AUPH Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -78.0 million USD | 175.5 million USD |
| 2022 | -108.2 million USD | 134.0 million USD |
| 2021 | -181.0 million USD | 45.6 million USD |
| 2020 | -102.7 million USD | 50.1 million USD |
| 2019 | -123.8 million USD | 318000 USD |
| 2018 | -64.1 million USD | 463000 USD |
| 2017 | -70.8 million USD | 420000 USD |
| 2016 | -23.3 million USD | 173000 USD |
| 2015 | -18.6 million USD | 235000 USD |
| 2014 | -16.6 million USD | 278000 USD |
| 2013 | -2.5 million USD | 948561 USD |
| 2012 | -9.7 million USD | 6.2 million USD |
| 2011 | -2.4 million USD | 927522 USD |
| 2010 | -3.7 million USD | 3.4 million USD |
| 2009 | -7.6 million USD | 4.1 million USD |
| 2008 | -15.9 million USD | 3.9 million USD |
| 2007 | -33.8 million USD | 2.3 million USD |
| 2006 | -22.9 million USD | 3.5 million USD |
| 2005 | -29.1 million USD | 1.2 million USD |
| 2004 | -22.6 million USD | 1.3 million USD |
| 2003 | -14.6 million USD | 7.7 million USD |
| 2002 | -365874 USD | 11.9 million USD |
| 2001 | -7.4 million USD | 5.3 million USD |
| 2000 | -6.3 million USD | 902772 USD |
| 1999 | -1.2 million USD | 1.4 million USD |
| 1998 | -2.2 million USD | 781250 USD |
AUPH
Price: $5.16
52 week price:
Earnings Per Share: -0.54 USD
P/E Ratio: -15.29
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 2.2 million
Ebitda: -13.4 millionMarket Capitalization: 729.4 million